Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 29 October 2009, doi:10.1136/bmj.b4274
Cite this as: BMJ 2009;339:b4274
Shows promise in increasing pregnancy rates, but further studies are needed
| The first 150 words of the full text of this article appear below. |
In the United Kingdom, intrauterine insemination is the mainstay of fertility treatment carried out before couples embark on in vitro fertilisation. It is recommended by the National Institute for Health and Clinical Excellence (NICE) and by a recent international workshop1 for couples with mild male factor infertility, unexplained infertility, and mild endometriosis.2
Intrauterine insemination is attractive to couples who want minimal drug treatment, low costs, and fertilisation in the fallopian tube, as in natural conception. Many people who have religious or moral objections to in vitro fertilisation find intrauterine insemination acceptable, and the procedure is often provided in small local clinics that cannot support more costly and complex treatments. However, the approach to intrauterine insemination varies, and it is unclear which approach is best.1 3 Success rates vary from 5% to 70%.4 In the linked randomised controlled study (doi:10.1136/bmj.b4080), Custers and colleagues compared the effectiveness of 15 minutes of
William L Ledger, professor
1 Academic Unit of Reproductive and Developmental Medicine, University of Sheffield, Sheffield Teaching Hospitals NHS Trust, Sheffield S10 2SF
W.Ledger@Sheffield.ac.uk